In summary, a novel CS-based nano-complex modified with carboxyl and functionalized with DNA-Apt (as targeting and therapeutic agent) was designed and synthesized for the effective delivery of NO into EGFR-positive breast cancer cells. Here, EGFR is linked to breast cancer.